Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease
Anikó Gál, Mária Judit Molnár(Istituto delle Scienze Neurologiche di Bologna), Lívia Dézsi(University of Szeged), Ágnes Herczegfalvi, Zsuzsanna Almássy(Boston Children's Hospital), Katalin Szakszon(Boston Children's Hospital), Zoltán Grosz(Semmelweis University), Ildikó Szatmári(Semmelweis University), Veronika Harmat(Eötvös Loránd University), Eniko Balku(Jósa András Múzeum), Beáta Borsos(Semmelweis University), Zita Jobbágy(Bács-Kiskun Megyei Kórház), Laszló Jávor(Petz Aladár Megyei Oktató Kórház), Levente Kerényi(Fejér Megyei Szent György Egyetemi Oktató Kórház), Ágnes Sebök(University of Pecs)
Cited by 5
Related Papers
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
|Orphanet Journal of Rare Diseases|2011|237
Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS)
|Journal of Inherited Metabolic Disease|2009|183
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
|Neuromuscular Disorders|2017|128
The present state and perspectives of micronucleus assay in radiation protection. A review
|International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes|1987|112